Other
Cd Private Equity Fund Ii (CD2)
CD Private Equity Fund II (CD2) is an ASX-listed investment trust providing investors with exposure to a portfolio of US-based private equity funds. Managed by Cordish Private Ventures, the underlying funds focus on acquiring and growing lower middle-market companies across the United States. CD2's structure gives Australian investors access to a diversified portfolio of unlisted international growth companies.
Market Cap
A$24M
Shares on Issue
N/A
Price Chart
AI Analysis
As a mature fund of funds with a micro-cap valuation of A$26M, CD2 is primarily in a harvest phase, focusing on the realisation of its underlying private equity investments. The key metric for performance is its Net Tangible Assets (NTA) per unit, which is reported monthly. The fund's share price frequently trades at a notable discount to its NTA, reflecting market sentiment, the illiquidity of the stock, and the opaque nature of unlisted asset valuations. Recent performance is dictated by currency movements (AUD/USD) and valuation changes or exits within the US-based portfolio companies.
The growth outlook for CD2 is driven by the successful exit of its underlying portfolio companies. Future catalysts are almost entirely linked to announcements of these realisations, which can unlock significant value and lead to capital returns or special distributions for unitholders. The fund's strategic direction is to manage the existing portfolio to maximize exit values and return capital to investors over the coming years, rather than making significant new investments. The timing and value of these exits are the primary determinant of future returns and remain the key uncertainty for investors.
Bull Case
- • The share price often trades at a significant discount to the reported Net Tangible Asset (NTA) value, presenting a potential value opportunity if this gap narrows.
- • Successful exits of underlying portfolio companies in the US market at or above carrying value can trigger special distributions and a re-rating of the NTA.
- • Provides unique, diversified exposure to the US lower middle-market private equity asset class, which is typically inaccessible to Australian retail investors.
Bear Case
- • High illiquidity due to its micro-cap size, leading to a wide bid-ask spread and significant price volatility, making it difficult to trade large positions.
- • The valuation of the underlying unlisted assets (NTA) is subjective and can be written down, especially during economic downturns, impacting the perceived value.
- • The 'fund of funds' structure involves multiple layers of management fees, which can create a drag on overall investment returns compared to direct investments.
Recent Announcements
Quarterly Activities Report
Highlights production updates, capital allocation priorities, and FY guidance commentary.
Investor Presentation
Strategic outlook with market positioning and growth pipeline.
FAQs
What does CD2 do?
CD2 is an ASX-listed trust that invests in a portfolio of private equity funds in the United States. It acts as a 'fund of funds', allowing Australian investors to gain indirect exposure to a diversified range of unlisted, small-to-medium-sized American growth companies.
Is CD2 a good investment?
CD2 is a high-risk, speculative investment. The potential appeal lies in buying at a discount to its asset value (NTA) and receiving capital distributions from successful business sales. However, risks include high stock illiquidity, uncertainty in valuing the underlying private assets, and layered fees.
What drives CD2's share price?
The key drivers are its monthly NTA announcements, news of successful sales (realisations) of portfolio companies, the size of any capital distributions to unitholders, and the prevailing discount or premium of the share price to its NTA.
Key Metrics
Related Stocks
Other
ACQAcorn Capital Investment Fund Limited
A$0.95
30.1% 1Y
Acorn Capital Investment Fund Limited (ACQ) is an ASX-listed investment company (LIC) managed by specialist microcap investor Acorn Capital. The fund provides investors with access to a diversified portfolio of emerging Australian micro and small-cap companies, including both listed and unlisted entities. Its investment strategy focuses on identifying early-stage, high-growth potential businesses across various sectors.
Other
AFIAustralian Foundation Investment Company Limited
A$6.79
-4.1% 1Y
Australian Foundation Investment Company Limited (AFI) is a closed-end diversified investment trust operating solely in Australia, focusing on investing in a portfolio of mainly ASX-listed shares to provide long-term returns to shareholders through a combination of dividends and capital growth. Key holdings historically include blue-chip Australian stocks across various sectors. AFI is managed by Australian Foundation Investment Company Ltd itself, emphasizing a conservative investment approach.
Other
AIQAlternative Investment Trust
A$1.45
-1.9% 1Y
Alternative Investment Trust (ASX: AIQ) is a listed investment trust (LIT) on the Australian Securities Exchange. It provides investors with exposure to a diversified portfolio of alternative assets, primarily through investments in a global diversified portfolio of hedge funds. The trust aims to generate long-term capital growth and income for its unitholders by accessing investment strategies not typically available to retail investors.